On May 23, 2018, we published revised versions of our Privacy Policy and User Agreements. Please read these updated terms and take some time to understand them. Your use of our services is subject to these revised terms.
Yes, I Agree.
Save 20% on PRs and Gain Exclusive Benefits with NNW Prime! Click to View Details
WednesdayOct 12, 2016 1:53 pm

eXp World Holdings, Inc. (EXPI) Teams with New Story to Provide Housing in Haiti – Exceeds Funding Goals within Hours

eXp Realty, the Agent-Owned Cloud Brokerage® owned by eXp World Holdings, Inc. (OTCQB: EXPI), this morning announced its newly formed partnership with New Story, a non-profit that builds homes in impoverished areas such as Haiti. eXp Realty initially announced the partnership last week during its third annual company convention in San Antonio, Texas. The company challenged its agents and brokers to raise $18,000 to fund the construction of three new homes in Haiti - a goal achieved within three hours of the announcement, raising a total of $35,000 to fund additional construction. To view the full press release, visit: http://nnw.fm/YeSy4…

Continue Reading

WednesdayOct 12, 2016 1:52 pm

Moxian, Inc. (MOXC) Technology Designed to Optimize Social Media for Consumer Engagement

Social media has had a profound impact on the way businesses reach and engage with existing and potential customers. Proper use of the tool hits numerous key aspects of consumer engagement and satisfaction, including customer service, product information, advertising and more. Social customer relationship management (CRM) programs, such as the one developed for the Chinese market by Moxian, Inc. (OTCQB: MOXC) can play a vital role in streamlining the possibilities and tracking pertinent information to better build an engagement strategy. To view the full article, visit: http://nnw.fm/DkVq3 About Moxian, Inc. Moxian engages in the business of providing social marketing and…

Continue Reading

WednesdayOct 12, 2016 1:51 pm

Medical Transcription Billing, Corp.’s (MTBC) Latest Acquisition is Tell-tale of Aggressive Growth Strategy

Medical Transcription Billing (NASDAQ: MTBC) (NASDAQ: MTBCP), a leading provider of proprietary web-based electronic health records, practice management and mHealth solutions, recently acquired the assets of Texas-based MediGain, LLC and its affiliate, New Jersey-based Millennium Practice Management, LLC. The acquisition marks MTBC’s largest acquisition of revenue cycle management customer accounts and other assets since its IPO in 2014, and is expected to “contribute to our positive Adjusted EBITDA by the end Q1 2017." To view the full article, visit: http://nnw.fm/4Rbhe About MTBC Medical Transcription Billing, Corp. is a healthcare information technology company that provides a fully integrated suite of proprietary…

Continue Reading

TuesdayOct 11, 2016 11:24 am

Gevo, Inc. (GEVO) Produces World’s First Cellulosic Renewable Jet Fuel for Commercial Airline Use

Gevo (NASDAQ: GEVO) this morning announced its complete production of the world’s first cellulosic renewable jet fuel specified for commercial flights. The company said it successfully adapted its patented technologies to convert cellulosic sugars derived from wood waste into renewable isobutanol, which was then further converted into Gevo’s Alcohol-to-Jet fuel (ATJ) fuel that meets ASTM D7566 specification for commercial flights. The revisions to the ASTM D7566 specification, which occurred earlier this year, includes ATJ derived from renewable isobutanol regardless of the carbohydrate feedstock such as cellulosics, corn, sugar cane, molasses, etc. The news triggered an early morning spike in shares before…

Continue Reading

TuesdayOct 11, 2016 11:22 am

Staffing 360 Solutions, Inc. (STAF) Shares Up 12% on Increased Revs, Trimmed Loss in Fiscal Q1 2017

Shares of Staffing 360 Solutions, Inc. (NASDAQ: STAF) are more than 12% higher in Tuesday’s morning trade after the company posted higher revenues and a narrowed loss for the fiscal first quarter ended August 31, 2016. Revenue increased 33.1% to $47.8 million, compared to $35.9 million in the fiscal quarter ended August 31, 2015. Net loss decreased 22.2% to $1.3 million, compared to a net loss of $1.7 million in the fiscal quarter ended August 31, 2015. Gross profit increased 34.3% to $8.5 million, compared to $6.3 million in the fiscal quarter ended August 31, 2015. Adjusted EBITDA increased 184%…

Continue Reading

TuesdayOct 11, 2016 11:20 am

Terra Tech Corp. (TRTC) Climbs 6% on Scheduled Opening of its Third Cannabis Dispensary in Nevada

Terra Tech Corp. (OTCQX: TRTC), a vertically integrated cannabis-focused agriculture company, this morning announced the grand opening of its latest Blüm retail dispensary scheduled for October 22, 2016. The-5,220-square foot facility, located at 1130 East Desert Inn Road in Las Vegas, will offer the company’s premium medical cannabis, flowers, shatters, waxes and oils, among other cannabis products. This is Terra Tech's third retail location in Nevada, in addition to the Western Las Vegas Dispensary and the South Decatur Boulevard Las Vegas Dispensary. The company also operates a Blüm dispensary in Oakland, California. News of the opening pushed shares nearly 6%…

Continue Reading

TuesdayOct 11, 2016 11:17 am

Nova LifeStyle, Inc. (NVFY) Trades 23% Higher on $15M Supply Agreement

Nova LifeStyle (NASDAQ: NVFY), a modern life style furniture company, this morning announced its $15 million annual product framework agreement with the Future Biz School (“FBS”) (www.futurebizschool.com), a Hong Kong and Malaysia-based professional training institute. Per the agreement, Nova LifeStyle will supply U.S.-made mattresses and other products to FBS, with actual sales subject to and fulfilled by specific orders from FBS. Nova LifeStyle said it has received “firm orders” for October and November of 2016 to supply $2 million worth of products. To view the full press release, visit: http://nnw.fm/L0kfJ About Nova LifeStyle Nova LifeStyle, Inc., a NASDAQ Global Markets…

Continue Reading

TuesdayOct 11, 2016 11:12 am

Biostar Pharmaceuticals, Inc. (BSPM) to Launch “Easy Breathing” Product in the People’s Republic of China, Shares Spike 16%

Shares of Biostar Pharmaceuticals, Inc. (NASDAQ: BSPM) surged more than 16% in Tuesday’s morning trade after the manufacturer and marketer of pharmaceutical and health supplement products in China announced the upcoming launch of its "Easy Breathing" product for the treatment of rhinitis and sinusitis. The product will be manufactured, distributed and sold in the People’s Republic of China, where the company is based. Sales will commence in November 2016. Rhinitis is irritation and inflammation of the mucous membrane inside the nose. Sinusitis is an inflammation or swelling of the tissue lining the sinuses. To view the full press release, visit:…

Continue Reading

MondayOct 10, 2016 12:23 pm

OurPet’s Company (OPCO) Partners with Paulee Cleantec Ltd. to Create Eco-Friendly Waste Management Solutions

OurPet’s Company (OTCQX: OPCO) today announced that it has teamed up with Israel-based Paulee Cleantec, an international leader in eco-friendly solutions for the management of human and animal waste, calling the new partnership a “viable catalyst of major innovative solutions to the environmental concerns of pet waste management.” Paulee Cleantec has developed a patented waste system to rapidly convert animal feces into an odor-free ash fertilizer, thereby reducing the damaging impact of pet waste management on the environment. The partnership will leverage both companies’ innovations to commercialize an initial, portable dog waste product, as well as to apply the technology…

Continue Reading

MondayOct 10, 2016 11:58 am

CytRx Corporation (CYTR) Presents Interim Clinical Trial Results for Aldoxorubicin Combination

CytRx (NASDAQ: CYTR) today presented interim results from its ongoing phase 1b/2 trail of aldoxorubicin in combination with ifosfamide/mesna in patients with advanced sarcomas, pushing shares higher in morning trade. At the European Society for Medical Oncology (ESMO) 2016 Congress being held in Copenhagen, Denmark, CytRx reported that: over 25% of sarcoma patients achieved a partial response for the target lesion while 61% had prolonged stable disease; six patients with unresectable tumors achieved greater than 50% tumor shrinkage, allowing some of them to become eligible for surgery; and there were no signs of cardiotoxicity, including in patients that received approximately…

Continue Reading

Contact us: 212.418.1217